EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

COVID-19 and Diarylamidines: The Parasitic Connection

John Hulme iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076583 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von John Hulme. Beteiligte Einrichtung: Department of Bionano Technology, Gachon Bionano Research Institute, Gachon University, 1342 Sungnam-daero, Sujung-gu, Seongnam-si 461-701, Republic …. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants (Omicron) continue to outpace and negate combinatorial vaccines and monoclonal antibody therapies targeting the spike protein (S) receptor binding domain (RBD), the appetite for developing similar COVID-19 treatments has significantly diminished, with the attention of the scientific community switching to long COVID treatments. However, treatments that reduce the risk of “post-COVID-19 syndrome” and associated sequelae remain in their infancy, particularly as no established criteria for diagnosis currently exist. Thus, alternative therapies that reduce infection and prevent the broad range of symptoms associated with ‘post-COVID-19 syndrome’ require investigation. This review begins with an overview of the parasitic–diarylamidine connection, followed by the renin-angiotensin system (RAS) and associated angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSSR2) involved in SARS-CoV-2 infection. Subsequently, the ability of diarylamidines to inhibit S-protein binding and various membrane serine proteases associated with SARS-CoV-2 and parasitic infections are discussed. Finally, the roles of diarylamidines (primarily DIZE) in vaccine efficacy, epigenetics, and the potential amelioration of long COVID sequelae are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Post-Acute COVID-19 SyndromePeptidyl-Dipeptidase ARenin-Angiotensin System

Stichwörter der Autor:innen

diarylamidineslong COVIDserine protease

Substanzen

Peptidyl-Dipeptidase A

Autor:innen und Institutionen

  • Department of Bionano Technology, Gachon Bionano Research Institute, Gachon University, 1342 Sungnam-daero, Sujung-gu, Seongnam-si 461-701, Republic of Korea.

ORCID-Profile: John Hulme

Zitieren

APA

Hulme, J. (2023). COVID-19 and Diarylamidines: The Parasitic Connection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076583

Vancouver

Hulme J. COVID-19 and Diarylamidines: The Parasitic Connection. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076583

BibTeX
@article{Hulme2023,
  author = {Hulme, John},
  title = {COVID-19 and Diarylamidines: The Parasitic Connection},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076583}
}
Kostenlos starten →